DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Ziemssen T, Neuhaus O, Hohlfeld R.
Risk-benefit assessment of glatiramer acetate in multiple sclerosis.
Drug Safety 2001;
24: 979-990
We do not assume any responsibility for the contents of the web pages of other providers.